Katten Muchin Rosenman’s legal advice will likely be the target of heavy scrutiny in the upcoming trial against former pharmaceutical executive Martin Shkreli—unless the government has its way.
Shkreli, who is set to go to trial on June 26, is expected to argue that he counted on attorneys from Katten for accurate legal advice only to find himself indicted for crimes he did not commit, according to his attorneys.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
